Mogliche Indikationen zur Behandlung mit 'Anti-Craving'-Medikamenten

Translated title of the contribution: Indications for a treatment with 'anti-craving' drugs

T. Wetterling*, C. Veltrup, K. Junghanns

*Corresponding author for this work
3 Citations (Scopus)


In the FRG the greatest portion of alcoholics only consultate a general practitioner. They often refuse further treatment although being motivated to abstain. The introduction of so-called 'anti-craving' drugs like Acamprosat offers the GPs a new therapeutic strategy. Thus, they will be confronted with the question, who should be treated with these new drugs. That's why, specialists should discuss the indications for an 'anti-craving' medication in time. According to the presented proposal 'anti-craving' drugs should be only prescribed to alcoholics clearly motivated for abstinence as well as therapy. Furthermore, they should have complained about craving in the context of relapses in the past.

Translated title of the contributionIndications for a treatment with 'anti-craving' drugs
Original languageGerman
Issue number5
Pages (from-to)323-330
Number of pages8
Publication statusPublished - 1996

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Indications for a treatment with 'anti-craving' drugs'. Together they form a unique fingerprint.

Cite this